Our RNA expression results were replicated in publicly available expression microarray datasets (Figure 2B) and importantly, these microarray data demonstrated a significant association between low‐MEGF10 expression and reduced relapse‐free survival in neuroblastoma patients, especially in MYCN non‐amplified tumors (Figure 2C). Here, MYCN is linked to neuroblastoma.